📖 IN REVIEW: #Prurigonodularis is linked to high rates of depression, anxiety, and suicidal ideation. A meta-analysis of 14 studies found patients with PN are about 1.3 times more likely to suffer from depression, 1.9 times more from anxiety, and 2 times more from suicidal thoughts compared to the general population. 🖇 Read more: https://lnkd.in/gFUtiv9e
About us
Dermatology Times is a leading news resource serving more than 16,000 dermatologists and other skin care professionals and focusing on the latest developments in dermatological practice, regulatory news, practice management, and new products. We strive to help practitioners understand and put into perspective developments that affect their profession and their business.
- Website
-
http://www.dermatologytimes.com
External link for Dermatology Times
- Industry
- Book and Periodical Publishing
- Company size
- 501-1,000 employees
- Headquarters
- Cranbury
- Type
- Public Company
Locations
-
Primary
Cranbury, US
Employees at Dermatology Times
Updates
-
🗞 IN THE NEWS: Review our recap of the latest news headlines in dermatology from the past week, including Skin Analytics' AI tool, parasitic worms and skin wound healing, and more. https://lnkd.in/g6gtZRC6
Derm In The News: August 25-31
-
❗️ICYMI: The US FDA recently granted Fast Track Designation to Innovent Biologics' IBI363, a PD-1/IL-2α bispecific antibody fusion protein therapy, for patients with unresectable locally advanced or metastatic #melanoma. The treatment is intended for individuals whose disease has progressed despite intervention with at least 1 prior PD-1/L1 inhibitor and systemic therapy. It is not intended for individuals with choroidal melanoma. 🖇 Read more: https://lnkd.in/g7zisA7S
IBI363 Monotherapy Granted Fast Track Designation in US for Advanced Melanoma
dermatologytimes.com
-
📹THE PATIENT PERSPECTIVE: Kristine Kucera, PA-C, MPAS, DHS, and Mickey Bryson discuss Mickey's atopic dermatitis case, including his treatment journey, regimen, quality of life, and overall resolution. Discover practical solutions for managing atopic dermatitis: https://ow.ly/JQqy50TfUW4
-
-
🔑✨ TOP PSORIASIS TAKEAWAYS FROM AUGUST: #PsoriasisAwarenessMonth was packed with updates on psoriatic disease: Alumis Inc.’s ESK-001 phase 3 trial, the impact of green spaces on risk, and apremilast becoming available for pediatric patients. Explore our comprehensive recap to stay informed on these important developments and more. ⬇️ https://lnkd.in/gtmadrk9
-
-
❗️ICYMI: Evommune, Inc. has launched a phase 2 trial for EVO756, a selective small molecule targeting MRGPRX2, aimed at treating chronic inducible urticaria. The trial, involving 30 patients across 15 U.S. sites, will test EVO756's effectiveness and safety over a 4-week period. 🖇 Read more: https://lnkd.in/gJHp65QE
Phase 2 Trial Begins for EVO756 in Chronic Inducible Urticaria
dermatologytimes.com
-
🧬 STUDY FINDINGS: Combination therapy including oral silymarin and hair follicle transplantation yielded a significant decrease in measurable #vitiligo extent. Researchers also reported an increase in perifollicular repigmentation following combined treatment. 🖇 Read more: https://lnkd.in/g4DsbtR2
Oral Silymarin Plus Hair Follicle Transplantation Efficacious in Refractory Vitiligo
dermatologytimes.com
-
🗓 WEEKLY ROUNDUP: Review our recap of the latest dermatology news and study coverage from the past week, including the AHEAD recommendations, positive long-term results for roflumilast cream 0.05% in pediatric patients, and more. https://lnkd.in/gSpUXjGD
The Weekly Roundup: August 26-30
-
📚 STUDY FINDINGS: A study on #atopicdermatitis and photosensitivity reviewed 139 patients, finding varying UV sensitivities and noting that photosensitivity can evolve. The study emphasizes the need for consistent diagnostic criteria and ongoing phototesting. 🖇 Read more: https://lnkd.in/gaaTz4De
Defining Photosensitivity in Atopic Dermatitis
dermatologytimes.com